Power Law company profile

Intercept Pharmaceuticals

Biotech & Life Sciences · New York City, United States · Founded 2002 · IPO 2012 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$456M

Market cap · 2026

Revenue

$361M

Latest reported FY

Investors

2 investors on Intercept Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Series B+ 1 investor entered at this stage

Global footprint

Web traffic by country

10K monthly visits
across markets

🇺🇸 United States70%

🇬🇧 United Kingdom13%

🇮🇳 India8%

🇨🇦 Canada7%

🏳️ Pakistan2%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo